We are delighted to host Rinn Advanced Therapies at Trinity College Dublin, and are inspired by the transformative potential of this National Research Centre. Together with our collaborators, we are advancing impactful research that has the power to change lives, and brings us closer to a future where patients in Ireland can benefit from personalised, cutting-edge cellular immunotherapies developed and delivered by the Centre.
I am especially proud that our colleagues, Professor Sakis Mantalaris, Professor of Pharmaceutical Biology in the School of Pharmacy and Pharmaceutical Sciences, is providing visionary leadership as Director of Rinn Advanced Therapies, along with Professor Nicki Panoskaltsis, Professor of Personalised Therapeutics, who is co-leading the research and translation. The Centre will also have significant involvement from our School's academics: Prof David Finlay, Prof Anne Marie Healy, Prof Lorraine O’Driscoll, Prof Cristín Ryan, Dr Deirdre D’Arcy and Dr Bernard Naughton.
We are also delighted that Rinn Advanced Therapies will form a strategic role in advancing the Canada-Ireland Partnership, as outlined in the Joint Statement between Taoiseach Micheál Martin and the prime minister of Canada, Mark Carney, in June 2026. Under a Memorandum of Understanding between Rinn Advanced Therapies and the Centre for Commercialization of Regenerative Medicine (CCRM), the two countries will explore opportunities for further collaboration to support resilient health systems.
Driven by ambition and purpose, it is our mission to firmly establish the School as a global leader in Advanced Therapies, shaping innovation, accelerating discovery, and improving patient outcomes both nationally and internationally. Our goals are to develop ground-breaking advanced therapies and to train pharmacists and industry professionals in manufacturing, regulation, and clinical application of these new medicines towards improved patient outcomes.
Dr Astrid Sasse, Head of the School of Pharmacy and Pharmaceutical Sciences
More information about the Research Ireland-funded Rinn centres can be found here.
/filters:format(webp)/filters:quality(100)/prod01/channel_3/media/tcd/pharmacy/images/news-/Mantalaris-Headshot.jpg)
Professor Sakis Mantalaris is currently the Don Panoz Chair at the School of Pharmacy & Pharmaceutical Sciences at Trinity College Dublin, and also Principal Investigator at the National Institute for Bioprocessing Research & Training /filters:format(webp)/filters:quality(100)/prod01/channel_3/media/tcd/pharmacy/images/news-/Prof.-Nicki-Panoskaltsis.jpg)
Professor Panoskaltsis is a Physician-scientist with a niche interest in translational interdisciplinary research and personalised therapeutics, focused in Haemato-Oncology. She completed her MD at the University of Toronto (Canada), clinical training and American Board Certification in Internal Medicine, Haematology and Bone Marrow Transplantation at the University of Rochester (USA) and a PhD in Immunology at Imperial College London (UK) where she stayed on as faculty until 2018. She then moved her programme to the Winship Cancer Institute at Emory University, where she was Senior Faculty within the Department of Hematology & Medical Oncology, an Attending Physician in the Leukemia programme and Program Faculty in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Institute of Technology and Emory University. She is now Professor and Chair of Personalised Therapeutics at Trinity College Dublin. She co-leads an interdisciplinary research lab with unique expertise in bone marrow organoid cultures, cytokine release syndrome, cell bioprocessing and in silico modelling techniques focussed on creating novel approaches to personalised immunotherapeutics including cell therapies.
